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 S2 
Supporting Information 
 
Contained within the supporting information are DNA sequencing results and chromatograms, 
information on the Fos-Library used for the PCA stages, and mass spectrometry data relating to the 
synthetic peptides.  
 
 
 
 
Figure S1. Overview of PCA passages. The options (red) were randomised at 11 positions and the 
residue selections for each stage shown in blue. At both a3 and e5, there were no changes in residue 
from the first passage (Asn and Gln, respectively). 
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Fos-Library. The degenerate DNA sequence was used to define the library used at the PCA 
stages.  
 
Figure S2: The degenerate library shown was created from the 34 unique isPCA/isCAN sequences to 
result in a small high quality and PCA-accessible library of 23,328 sequences, which was expanded 
further to 31,104 sequences with the addition of His at one core position.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S3. Fos Library Chromatogram. Sequence data from the second (and final) passage (P2) showed 
the selection results from 11 randomised positions in the sequence (highlighted in red). Glu residues 
were selected at g0, e1, and g4 whereas Lys was selected at e3 – with Gln residues on g2 and e5. Ile was 
chosen at a1 and a5, Leu at a2 and a4, and Asn at a3. 
23328 Fos-Library (addition of unwanted H makes size = 31,104) 
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Figure S4. Electrospray Mass Spectrometry data from purified cJun and cFos demonstrating correct 
+3 - +5 m/z of cJun A and cFos (B) 
 
 
 
 
Figure S5. Electrospray Mass Spectrometry data from purified FosUPCA and JunWCANDI 
demonstrating correct +3 - +5 m/z of FosUPCA (A) and JunWCANDI (B) 
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